WASHINGTON, DC--(Marketwire - March 16, 2010) - The forum, Invest in Tomorrow. Invest in Research, brings together nationally recognized leaders in health research from government, industry, academia, media, and patient advocacy organizations. Battelle's Health and Life Sciences Global Business President Barbara Kunz will participate in the panel discussion "Translating Discoveries into Better Health," followed by a Q&A session. The panel is to be moderated by Michael Kinsley of The Atlantic.
The event is scheduled from noon to 3 p.m., March 16, at the National Press Club at 529 14th Street NW, 13th Floor.
Kunz is accountable for Battelle's portfolio of businesses and capabilities for government and commercial clients within the pharmaceutical, biotechnology, medical devices and diagnostics, public and environmental health, and agrifood industries. In addition, she is responsible for the relationship between Battelle and the United States Department of Health and Human Services agencies, such as the Centers for Disease Control, the National Institutes of Health, the National Institute for Allergy and Infectious Diseases, and the National Institute of Environment Health Sciences, as well as the Environmental Protection Agency.
She joined Battelle from Fisher Scientific International, where she held the position of Senior Vice President and General Manager for Fisher Biosciences.
Kunz has a B.S. in Chemistry and in Biology from Thiel College, an M.S. in Polymer Science from the University of Akron and qualified in the International Executive Program, INSEAD in Fontainebleau, France.
For more information, visit www.battelle.org.
Contact Information:
Media contacts
Katy Delaney at (614) 424-7208 or